Norwegian Cancer Precision Medicine Implementation Consortium
Register now: Cancer Crosslinks 2022
tor. 27. jan.
|Oslo Cancer Cluster Innovation Park
Cancer Crosslinks is an educational meeting series which promotes interactions between researchers and clinicians, and encourages translational and clinical research to support collaborations to advance the development of innovative cancer treatments. For details see www.cancercrosslinks.com
Time & Location
27. jan. 2022, 11:30 – 16:00
Oslo Cancer Cluster Innovation Park, Ullernchausseen 64-66, 0379 Oslo, Norge
About the event
Cancer Crosslinks 2022 will feature updates about the most recent progress in the understanding of tumor evolution and how it impacts cancer diagnostics and treatment:
- Tracking Cancer Evolution through the Disease Course: Impact on Diagnostics and Treatment Decisions Today and Tomorrow, Mariam Jamal-Hanjani, UCL Cancer Institute London, UK
- Current and Future Methods of Predicting Response to Immunotherapy, David Rimm, Yale University School of Medicine, New Haven, USA
- Developing Early Phase Immunotherapy Trials / Neoadjuvant Treatments with Targeted & Immunotherapies, Martin Schuler, University Hospital Essen, Germany
- Update on Precision Therapy for Gynecological Cancers, Focus on Endometrial (Uterine) Cancer – Molecular Subtypes & Emerging Treatment Options (Including I-O), Angela George, Royal Marsden Hospital, London, UK
- Advances in Multiple Myeloma Treatment Using Proteasome Inhibitors (The Proteasome and Proteasome Inhibitors: From Biology to Clinical Impact), Christoph Driessen, Kantonsspital St. Gallen, Switzerland
- Gut Microbiome in the Immunotherapy Arena: From Biomarker to Therapeutics, Bertrand Routy, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Canada
Register here to attend the event, or press the RSVP-button further up.
For more information, go to January 2022 (cancercrosslinks.com)